Skip to main content
. 2011 Feb 4;118(5):564–577. doi: 10.1111/j.1471-0528.2010.02837.x

Table 3.

Description of ECV procedures

Description of procedures Early ECVn (%) Delayed ECVn (%)
n = 765 n = 769

Time from randomisation to first ECV procedure
≤7 days 571 (74.6) 10 (1.3)
>7 days 44 (5.8) 451 (58.7)
No ECV procedure undertaken 150 (19.6) 308 (40.1)
Reasons for no ECV procedure*
 Spontaneous version 106 (13.9) 194 (25.2)
 Mother declined ECV 29 (3.8) 47 (6.1)
 Developed contraindication to ECV 14 (1.8) 33 (4.3)
 Mother delivered before ECV 1 (0.1) 34 (4.4)
 Clinician declined 3 (0.4) 6 (0.8)
 Logistics 2 (0.3) 1 (0.1)
 Other 0 2 (0.3)
ECV procedure 615 (80.4) 461 (60.0)

n = 615 n = 461

Gestational age at first ECV procedure
Median (weeks) (5–95th centile) 35.1 (34.0, 35.9) 37.3 (36.9, 37.9)
 <340/7 14 (2.3) 0 (0.0)
 340/7–356/7 584 (95.0) 5 (1.1)
 360/7–366/7 12 (2.0) 26 (5.6)
 ≥370/7 5 (0.8) 430 (93.3)
Fetal presentation before first ECV procedure
 Frank breech 372 (60.5) 275 (59.7)
 Complete breech 189 (30.7) 144 (31.2)
 Footling breech 31 (5.0) 24 (5.2)
 Unknown breech 6 (1.0) 1 (0.2)
 Transverse/oblique lie 17 (2.8) 17 (3.7)
Position of breech at first ECV procedure
 Sacrum anterior 120 (20.1) 91 (20.5)
 Sacrum posterior 71 (11.9) 47 (10.6)
 Sacrum transverse 353 (59.0) 266 (60.0)
 Unknown 54 (9.0) 40 (9.0)
Station of presenting part before first ECV procedure
 Floating 236 (38.4) 121 (26.3)
 Dipping 244 (39.7) 209 (45.3)
 Well into the pelvis orengaged 122 (19.8) 124 (26.9)
 Unknown 13 (2.1) 7 (1.5)
Fetus easily palpated before first ECV procedure
 Yes 518 (84.2) 414 (89.8)
 No 94 (15.3) 45 (9.8)
 Unknown 3 (0.5) 2 (0.4)
Use of tocolytics for ECV
 During all ECV procedures 419 (68.1) 316 (68.6)
 During some ECV procedures 10 (1.6) 8 (1.7)
 During no ECV procedures 186 (30.2) 136 (29.5)
Tocolytics used*
 Betamimetic 335 (54.5) 252 (54.7)
 Nitric oxide donor 36 (5.9) 23 (5.0)
 Oxytocin antagonist 29 (4.7) 30 (6.5)
 Calcium channel blocker 27 (4.4) 15 (3.3)
 Prostaglandin synthetase inhibitor 19 (3.1) 20 (4.3)
 Magnesium sulphate 0 1 (0.2)
Use of epidural for one or more procedures 0 (0.0) 0 (0.0)
Use of spinal for one or more procedures 1 (0.2) 0 (0.0)
 Number having same spinal for delivery 0 (0.0) 0 (0.0)
Success of ECV procedures
Any ECV procedure successful 329 (53.5) 201 (43.6)
 Only one procedure undertaken 536 (87.2) 426 (92.4)
 First procedure successful 316 (51.4) 194 (42.1)
 Two procedures undertaken 73 (11.3) 34 (7.4)
 Second procedure successful 22 7
 More than two procedures undertaken 6 (1.0) 0 (0.0)
 Third or subsequent procedure successful 3
Ease with which first successful ECV performed§
 Very easy 104 (32.9) 43 (22.2)
 Somewhat easy 121 (38.3) 81 (41.8)
 Neither easy nor difficult 55 (17.4) 40 (20.6)
 Somewhat difficult 29 (9.2) 27 (13.9)
 Very difficult 6 (1.9) 3 (1.6)
Reasons for discontinuing first ECV*
 Unable to turn fetus 211 (34.3) 187 (40.6)
 Unable to lift breech frompelvis 97 (15.8) 93 (20.2)
 Maternal discomfort 74 (12.0) 61 (13.2)
 Non-reassuring fetal heartrate 11 (1.8) 11 (2.4)
 Obese/unable to palpate 11 (1.8) 5 (1.1)
 Other 4 (0.7) 6 (1.3)
Maternal and fetal complications during ECV*
 Non reassuring fetal heartrate 21 (3.4) 16 (3.5)
 Contractions 1 (0.2) 2 (0.4)
 Hypotension 1 (0.2) 2 (0.4)
 Vaginal bleeding/suspected abruption placenta 0 1 (0.2)
Fetal presentation after first ECV
 Cephalic 316 (51.4) 194 (42.1)
 Breech 283 (46.0) 250 (54.2)
 Transverse lie 16 (2.6) 17 (3.7)
Presentation of fetus after final ECV
 Cephalic 328 (53.3) 200 (43.4)
 Breech 275 (44.7) 246 (53.4)
 Transverse lie 12 (2.0) 14 (3.0)
Pain during first ECV
Adjusted Mean (SE)** 40.6 (1.06) 45.2 (1.2)
*

May be more than one reason given.

Other reasons in delayed group included an unstable lie and an unfavourable position for ECV with spines posterior.

§

One missing value for early group.

Fifteen missing values in the early group; six missing values in the delayed group.

**

Adjusted for parity, maternal age and weight, and anterior placenta; P = 0.0001.